[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212-220-6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 34, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2022, "totalPay": 956101, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Schond L. Greenway M.B.A.", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 343283, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 42, "title": "Chief Medical Officer", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": 663630, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miriam Halperin Wernli Ph.D.", "age": 70, "title": "Executive President", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 552464, "exercisedValue": 0, "unexercisedValue": 1030416}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 66, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": 312209, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-founder", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carrie F. Liao CPA, CGMA", "title": "VP & Chief Accounting Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francois P. Lilienthal M.B.A., M.D.", "title": "Chief Commercial Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 3, "overallRisk": 6, "governanceEpochDate": 1711929600, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.53, "open": 9.54, "dayLow": 8.85, "dayHigh": 9.66, "regularMarketPreviousClose": 9.53, "regularMarketOpen": 9.54, "regularMarketDayLow": 8.85, "regularMarketDayHigh": 9.66, "beta": 2.531, "forwardPE": -5.94, "volume": 1646361, "regularMarketVolume": 1646361, "averageVolume": 2231746, "averageVolume10days": 1397500, "averageDailyVolume10Day": 1397500, "bid": 8.88, "ask": 8.95, "bidSize": 600, "askSize": 400, "marketCap": 628163904, "fiftyTwoWeekLow": 2.41, "fiftyTwoWeekHigh": 12.22, "fiftyDayAverage": 7.8681, "twoHundredDayAverage": 4.678125, "currency": "USD", "enterpriseValue": 282713664, "floatShares": 33107540, "sharesOutstanding": 70501000, "sharesShort": 7226402, "sharesShortPriorMonth": 4220658, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.1025, "heldPercentInsiders": 0.024149999, "heldPercentInstitutions": 0.25397, "shortRatio": 1.69, "shortPercentOfFloat": 0.1031, "bookValue": 1.901, "priceToBook": 4.6870065, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -95732000, "trailingEps": -2.44, "forwardEps": -1.5, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MNMD", "underlyingSymbol": "MNMD", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "firstTradeDateEpochUtc": 1479220200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "82effaa6-cea3-362e-b9a1-33a692529ba0", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.91, "targetHighPrice": 75.0, "targetLowPrice": 16.0, "targetMeanPrice": 30.86, "targetMedianPrice": 22.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 99704000, "totalCashPerShare": 2.412, "totalDebt": 14129000, "quickRatio": 3.092, "currentRatio": 3.221, "debtToEquity": 18.083, "returnOnAssets": -0.39837003, "returnOnEquity": -0.83589995, "freeCashflow": -25911250, "operatingCashflow": -64365000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-19"}]